Trials: Pressemitteilungen - Kategorie - Seite 5

Trials

Category / Pharmaceuticals & Biotech / Trials


Clinical Validation Study Supporting the Use of BREVAGenplus(R) in Breast Cancer Risk Assessment

MELBOURNE, AUSTRALIA: MELBOURNE, AUSTRALIA -- (Marketwired) -- 12/17/14 -- Molecular diagnostics company Genetic Technologies Limited (ASX: GTG) (NASDAQ: GENE) ("Company") announces that findings from a new rese ...

Cromos Pharma Launches Risk-Sharing Partnerships Program With Biotech and Pharma Companies

PORTLAND, OR: PORTLAND, OR -- (Marketwired) -- 12/15/14 -- , an international full-service CRO announced today the implementation of a risk-sharing platform partnering with biotech, pharma and device companies tha ...

Databean Managing Partner, Nuala Ronan, Wins Two Prestigious Awards

WESTCHESTER, NY: Nuala Ronan Honored With a Stevie Award and a 914INC Women in Business Award ...

RepliCel Life Sciences to Present at World Stem Cell Summit 2014

VANCOUVER, BRITISH COLUMBIA: Over multiple sessions, Lee Buckler will present a RepliCel update, participate in session panels, and lead an experts' roundtable discussion ...

Proteostasis Therapeutics and Astellas Announce Collaboration for Research, Development and Commercialization of Therapies Modulating the Unfolded Protein Response

CAMBRIDGE, MA. and TOKYO, JAPAN: CAMBRIDGE, MA. and TOKYO, JAPAN -- (Marketwired) -- 11/04/14 -- Proteostasis Therapeutics, Inc. ("Proteostasis Therapeutics"), a company developing novel therapeutics to address diseases ca ...

Promising Data Presented at the Chicago Multidisciplinary Symposium on Thoracic Oncology From an Investigator-Sponsored Trial of Peregrine Pharmaceuticals' Bavituximab in Combination With Pemetrexed and Carboplatin in Front-Line Non-Small Cell Lung Cancer

TUSTIN, CA: Favorable Trends in Both Overall Response Rates of 35% and Median Overall Survival of 12.2 Months Continue to Support Bavituximab's Potential in NSCLC Lead Immuno-Oncology Antibody Bavituximab in ...

Corcept Therapeutics to Announce Third Quarter Financial Results and Host Conference Call

MENLO PARK, CA: MENLO PARK, CA -- (Marketwired) -- 10/28/14 -- Corcept Therapeutics Incorporated (NASDAQ: CORT) today announced it will report third quarter financial results and provide a corporate update on Novemb ...

Data to Be Published in the Journal of Immunology Research Support Phosphatidylserine (PS) as a Potential Target in Ebola Infection

TUSTIN, CA: Peer-Reviewed Data Show Peregrine Pharmaceuticals' PS-Targeting Antibody Bavituximab Exhibits Specific and Strong Binding to Ebola Virions and Ebola Virus-Infected Cells In Vitro; Data Supplement ...

StayinFront's Cloud-Based Biopharma CRM to Support a New Specialty Sales Team Launch

FAIRFIELD, NJ: StayinFront Life Sciences CRM and Analytics Solution to Support a New Specialty Sales Force With Integrated Capabilities for Advanced Customer Targeting, Closed Loop Marketing (CLM), and Performance T ...

Regen BioPharma Submits Experimental Protocol to FDA for HemaXellerate Aplastic Anemia Trial

SAN DIEGO, CA: Ongoing Dialogue With FDA Aimed at Initiating Clinical Trial for IND # 15376 ...

Aoxing Pharmaceutical Company, Inc. Announces Financial Results for 2014 Fiscal Year

JERSEY CITY, NJ: JERSEY CITY, NJ -- (Marketwired) -- 09/29/14 -- Aoxing Pharmaceutical Company, Inc. (NYSE MKT: AXN) ("Aoxing Pharma"), a specialty pharmaceutical company focusing on research, development, ...

Threshold Pharmaceuticals Announces Its Phase 3 Trial of TH-302 in Patients With Advanced Soft Tissue Sarcoma Will Continue as Planned Following Protocol-Specified Interim Analysis

SOUTH SAN FRANCISCO, CA: SOUTH SAN FRANCISCO, CA -- (Marketwired) -- 09/22/14 -- Threshold Pharmaceuticals, Inc. (NASDAQ: THLD) today announced that the Independent Data Monitoring Committee (IDMC) has completed the planned ...

SciClone to Present at BioCentury NewsMakers in the Biotech Industry Conference on September 26, 2014

FOSTER CITY, CA: FOSTER CITY, CA -- (Marketwired) -- 09/17/14 -- SciClone Pharmaceuticals, Inc. (NASDAQ: SCLN) today announced that Friedhelm Blobel, PhD, Chief Executive Officer, will present a corporate overview an ...

WorldCare Clinical Publishes Research Manuscript Demonstrating How a Central Image Review Can Reduce Overall Clinical Trial Costs

BOSTON, MA: Decreasing Image Interpretation Variability in Cancer Trials Can Result in Decreased Trial Sample Size, Thus Driving a Decrease in Trial Cost ...

International Stem Cell Corporation to Host Third Quarter 2013 Financial Results Conference Call at 11:00 a.m. ET on Wednesday, November 13, 2013

CARLSBAD, CA: CARLSBAD, CA -- (Marketwired) -- 11/06/13 -- International Stem Cell Corporation (OTCQB: ISCO) () a California-based biotechnology company developing novel stem cell based therapies and biomedical pr ...

Aoxing Pharmaceutical Company, Inc. Receives Notice of Noncompliance From NYSE MKT LLC

JERSEY CITY, NJ: JERSEY CITY, NJ -- (Marketwired) -- 10/30/13 -- Aoxing Pharmaceutical Company, Inc. (NYSE MKT: AXN) ("Aoxing Pharma"), a specialty pharmaceutical company focusing on research, development, ...

WorldCare Clinical Collaborates With Leading Researcher to Publish an Endpoint Assessment Committee Review Article

BOSTON, MA: BOSTON, MA -- (Marketwired) -- 10/29/13 -- WorldCare Clinical (WCC), a leading CRO focused on maximizing the precision and accuracy of independent assessments in clinical trials, today announced a ne ...

The Medicines Company Reports Third Quarter 2013 Financial Results

PARSIPPANY, NJ: 27% Increase in Third Quarter 2013 Net Revenue to $174.3 Million; 26% Increase YTD September 2013 Net Revenue to $502.9 Million; Net Income in Third Quarter 2013 Totals $7.8 Million or $0.12 per Share ...


Seite 6 von 10:   1  2  3  4  5 6 7  8  9  10 





 

Werbung



Facebook

Sponsoren

foodir.org The food directory für Deutschland
News zu Snacks finden Sie auf Snackeo.
Informationen für Feinsnacker finden Sie hier.

Firmenverzeichniss

Firmen die firmenpresse für ihre Pressearbeit erfolgreich nutzen
1 2 3 4 5 6 7 8 9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z